USFDA

1) Aptar’s Nasal Unidose Device Approved by U.S. FDA for First Nasal Rescue Treatment for Frequent Seizure Activity

Source:    

https://www.businesswire.com/news/home/20191209005155/en/Aptar%E2%80%99s-Nasal-Unidose-Device-Approved-U.S.-FDA

2) Amgen biosimilar to JnJ arthritis drug Remicade gets USFDA approval

Source: 

https://business.medicaldialogues.in/amgen-biosimilar-to-jnj-arthritis-drug-remicade-gets-usfda-approval/

 

3) Equillium Granted U.S. FDA Fast Track Designation for Itolizumab for the Treatment of Lupus Nephritis

Source: 

https://finance.yahoo.com/news/equillium-granted-u-fda-fast-211020365.html